The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1, first-in-human, open label, dose escalation study of MGD007, a humanized gpA33 x CD3 DART molecule, in patients with relapsed/refractory metastatic colorectal carcinoma.
 
John D. Powderly
Employment - BioCytics; Carolina BioOncology Institute
Leadership - BioCytics; Carolina BioOncology Institute
Stock and Other Ownership Interests - BioCytics; Bluebird Bio; Carolina BioOncology Institute; Juno Therapeutics; Kite, a Gilead company; Lion Biotechnologies; ZIOPHARM Oncology
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Curis; Genentech/Roche; TopAlliance BioSciences Inc
Speakers' Bureau - Bristol-Myers Squibb; Dendreon; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono; Genentech/Roche; Incyte; Lilly/ImClone; Macrogenics
Patents, Royalties, Other Intellectual Property - BioCytics is developing intellectual property for cellular immunotherapy
 
Herbert Hurwitz
Honoraria - Genentech/Roche; Lilly/ImClone
Consulting or Advisory Role - Acceleron Pharma; Amgen; Bayer; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; Regeneron; Sanofi; TRACON Pharma
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); TRACON Pharma (Inst)
 
David P. Ryan
Honoraria - UpToDate
Consulting or Advisory Role - Medimmune
Patents, Royalties, Other Intellectual Property - McGraw Hill Chapter Royalties
 
Daniel A. Laheru
No Relationships to Disclose
 
Naimish B. Pandya
Employment - MacroGenics; MedImmune
Stock and Other Ownership Interests - Macrogenics
Travel, Accommodations, Expenses - Macrogenics
 
Joanna Lohr
Employment - MacroGenics
Stock and Other Ownership Interests - MacroGenics
 
Paul A. Moore
Stock and Other Ownership Interests - GlaxoSmithKline; Medtronic; Teva
Patents, Royalties, Other Intellectual Property - Have patents based on work at MacroGenics, Human Genome Sciences and Celera
 
Ezio Bonvini
Employment - MacroGenics
Leadership - MacroGenics
Stock and Other Ownership Interests - Macrogenics
Research Funding - MacroGenics (Inst)
Patents, Royalties, Other Intellectual Property - Patent application and issued patents held by the US Federal Government (I); Patent applications and issued patents held by MGNX
 
Jon M. Wigginton
Employment - Macrogenics
Leadership - Macrogenics
Stock and Other Ownership Interests - Macrogenics
 
Todd S. Crocenzi
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb